<DOC>
<DOCNO>
EP-0003016
</DOCNO>
<TEXT>
<DATE>
19790725
</DATE>
<IPC-CLASSIFICATIONS>
C07D-498/00 C07D-513/00 A61P-25/00 A61K-31/55 A61P-25/24 C07D-241/24 C07D-513/04 <main>C07D-498/04</main> A61P-25/20 A61P-25/26 C07D-241/00 C07D-498/04 A61K-31/00 
</IPC-CLASSIFICATIONS>
<TITLE>
pyrazino-benzoxazepine and -benzthiazepine derivatives, processes for their production and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
sandoz agch<sep>sandoz ag<sep>sandoz aglichtstrasse 354002 baselch<sep>sandoz ag<sep>
</APPLICANT>
<INVENTOR>
leutwiler albert dr<sep>sorg dieter dr<sep>leutwiler, albert, dr.<sep>sorg, dieter, dr.<sep>leutwiler, albert, dr.kappelenring 40dch-3032 hinterkappelench<sep>sorg, dieter, dr.wylerstrasse 11ch-3014 bernech<sep>leutwiler, albert, dr.<sep>sorg, dieter, dr.<sep>leutwiler, albert, dr.kappelenring 40dch-3032 hinterkappelench<sep>sorg, dieter, dr.wylerstrasse 11ch-3014 bernech<sep>
</INVENTOR>
<ABSTRACT>
compounds of formula i,    wherein r₁ is hydrogen, alkyl of 1 to 4 carbon atoms,  hydroxyalkyl with a maximum of 4 carbon  atoms, which may be acylated by an alkanoyl  group of 2 to 18 carbon atoms, alkoxyalkyl with  a maximum of 6 carbon atoms, cycloalkyl of 3  to 6 carbon atoms, cycloalkylalkyl of 4 to 7  carbon atoms or a group of formula ii,    wherein r₅ is hydrogen, halogen, alkyl or  alkoxy of 1 to 4 carbon atoms, and   either i) x is -ch₂- and  n is 0, 1, 2 or 3 or   ii) x is -co- and  n is 1, 2 or 3 or   iii) x is -o- and  n is 2 or 3  and r₂ and r₃ are independently hydrogen,  halogen, trifluoromethyl or alkyl, alkoxy, alkylthio,  alkylsulfinyl or alkylsulfonyl, each of 1 to 4  carbon atoms and  r₄ is hydrogen, alkyl or alkoxy of 1 to 4 carbon  atoms,  z is -o- or -s-,  with the proviso that, when r₃ is trifluoromethyl,  alkoxy, alkylthio, alkylsulfinyl or  alkylsulfonyl, r₄ is other than alkoxy,  are useful for inducing sleep and treating psychotic disturbances  and depressions.  
</ABSTRACT>
<DESCRIPTION>
pyrazinobenzoxazepine derivatives, processes for their production and pharmaceutical compositions containing them the present invention relates to pyrazinobenzoxazepines, processes for their production and pharmaceutica compositions containing them. the present invention provides compounds of formula i, emi1.1 wherein r1 is hydrogen, alkyl of 1 to 4 carbon atoms, hydroxyalkyl with a maximum of 4 carbon atoms, which may be acylated by an alkanoyl group of 2 to 18 carbon atoms, alkoxyalkyl with a maximum of 6 carbon atoms, cycloalkyl of 3 to 6 carbon atoms, cycloalkylalkyl of 4 to 7 carbon atoms or a group of formula ii, emi2.1 wherein r5 is hydrogen, halogen, alkyl or al koxy of 1 to 4 carbon atoms, and either i) x is -ch2- and n is 0, 1, 2 or 3 or ii) x is -co- and n is 1, 2 or 3 or iii) x is -o- and n is 2 or 3 and r2 and r3 are independently hydrogen, halogen, trifluoromethyl or aikyl, alkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, each of 1 to 4 carbon atoms and r4 is hydrogen, alkyl or alkoxy of 1 to 4 carbon atoms, z is -o- or -s-, with the proviso that, when r3 is trifluoro methyl, alkoxy, alkylthio, alkylsulfinyl or alkylsulfonyl, r4 is other than alkoxy. any alkyl, alkoxy or alkylthio radical of 1 to 4 carbon atoms is preferably of 1 to 3 carbon atoms, especially 1 and 2 carbon atoms. hydroxyalkyl has preferably 2 or 3 carbon atoms. preferably the hydroxy group is attached to a carbon atom other than the carbon atom adjacent to the nitrogen atom. the alkoxy moiety in alkoxyalkyl is preferably located in the terminal position of the alkylene chain which preferably has 2 or 3, especially 2 carbon atoms. the alkoxy radical in alkoxyalkyl is preferably methoxy. cycloalkyl or the cycloalkyl moiety of cycloalkylalkyl is conveniently cyclopropyl or cyclopentyl. the alkyl moiety of cycloalkylalkyl is conveniently methyl. halogen means fluorine, chlorine, bromine or iodine, preferably fluorine or chlorine, especially chlorine. r1 is preferably hydrogen, alkyl or a group of formula ii, r5 is preferably hydrogen or fluorine. x is preferably -ch2- or -co-, n is preferably 1 or 3. r2 is preferably hydrogen, halogen or alkoxy. r3 is preferably hydrogen, halogen or alkyl. r4 is preferably hydrogen. when r2 and r3 are other than hydrogen, rq is preferably in position 8. z is preferably -0-. the present invention also provides a process for the production of a compound of formula i as defined above, which comprises reacting a compound of formula iii, emi4.1 wherein r2, r3, r and zare as defined above and y is a leaving group, with a compound of formula iv, emi4.2 wherein r1 is as defined above. the reaction may be effected in conventional manner for the production of similar compounds. y is preferably chlorine. the process may be conveniently effected at a tem perature ct fran 20 to 170 c in an inert organic solvent such as toluene, methylenchloride or dioxane. when r1 is hydrogen
</DESCRIPTION>
<CLAIMS>
what we claim is:    1. a compound of formula i, emi17.1       wherein r1 is hydrogen, alkyl of 1 to 4 carbon atoms,  hydroxyalkyl with a maximum of 4 carbon  atoms, which may be acylated by an alkanoyl  group of 2 to 18 carbon atome, alkoxyalkyl  with a maximum   of .6    carbon atoms, cycloalkyl  of 3 to 6 carbon atoms, cycloalkylalkyl of  4 to 7 carbon atoms or a group of formula ii, emi17.2          wherein r5 is hydrogen, halogen, alkyl or al  koxy of 1 to 4 carbon atoms, and  either i) x is -ch2- and  n is 0, 1, 2 or 3 or  ii) x is -co- and  n is 1, 2 or 3 or  iii) x is -0- and  n is 2 or 3  and r2 and r3 are independently hydrogen, halogen,    trifluorpmethyl    or   alkyl, alkoxy, 'alkylthio     alkylsulfinyl or alkylsulfonyl, each of 1 to  4 carbon atoms and  r4 is hydrogen,  alkyl or alkoxy of 1 to 4 carbon  atoms,  z is   -o-    or -s-,  with the proviso that, when r3 is trifluoro  methyl, alkoxy, alkylthio, alkylsulfinyl  or alkylsulfonyl, r4 is other than alkoxyor an acid addition salt thereof.    2. a process for the production of a compound of formula i, as defined in claim 1, which comprises reacting a compound of formula iii,   emi19.1       wherein   r21      r3, r4      and z    are as defined in claim   1.    and  y is a leaving group, with a   compound    of formula iv, emi19.2       wherein r1 is as defined in claim 1.    3. a compound of claim 1, wherein r1 is hydrogen, alkyl of 1 to 4 carbon atoms, hydroxyalkyl with a maximum of 4 carbon atoms or alkoxyalkyl with a maximum of 6 carbon atoms, r2 is hydrogen, halogen, alkyl or alkoxy of 1 to 4 carbon atoms, r3 and r4 are hydrogen and z is   -o-.       4. a compound of claim   i,    wherein r1 is hydrogen, alkyl of 1 to 4 carbon atoms, hydroxyalkyl with a maximum of 4 carbon atoms, alkoxyalkyl with a maximum of 6 carbon atoms or a group of formula ii, wherein r5 is hydrogen, halogen, alkyl or alkoxy of 1 to 4 carbon  atoms, and either i) x is   -oh2-    and n is o, 1, 2 or 3 or ii)   xis    -co- and n is 1, 2 or 3 or iii)   xis      -o-    and n is 2 or 3, r2 is hydrogen, halogen, alkyl or alkoxy of 1 to 4 carbon atoms, r3 is hydrogen, halogen,   trifluoromethyl    or alkyl, alkoxy or alkylthio, each of 1 to 4 carbon atoms, r4 is hydrogen, alkyl or alkoxy of 1 to 4 carbon atoms and z is   -o-.        5. a compound of claim 1, which is   11-(4-methyl-l-      piperazinyl)-pyrazino[2,3-b) [l,5)benzoxazepine.       6. a pharmaceutical composition comprising a compound of claim 1 in free base form or in pharmaceuti  cally acceptable acid addition salt form in association with a pharmaceutical carrier or diluent.  
</CLAIMS>
</TEXT>
</DOC>
